BAY 1213790, a fully human IgG1 antibody targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics - Thomas, D; Thelen, K; Kraff, S (Res Pract Thromb Haemost, 2019)